跳至主要内容
临床试验/CTRI/2023/11/060394
CTRI/2023/11/060394已完成Unknown

A Clinical Study to evaluate the photoallergic potential of Advancexo on healthy human subjects. - NI

Saffron Naturele Pdt. Ltd.0 个研究点目标入组 24 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Voluntary man/women between 18 and 65 years.
  • 2. Photo type III to V.
  • 3. Having apparently healthy skin on test area
  • 4. For whom the investigator considers that the compliance will be correct.
  • 5. Cooperating, informed of the need and duration of the examinations and ready to comply with protocol procedures.
  • 6. Having signed a Consent Form.
  • 7. Willingness to avoid intense UV exposure on test site (sun or artificial UV), during the course of the study.
  • 8. Willingness to avoid excessive water contact (for example swimming) or activity which causes excessive sweating (that is exercise, sauna), during the course of the study.
  • 9. Should be able to read and write (in English, Hindi or local language).
  • 10. Having valid proof of identity and age.

排除标准

  • 1. Pregnant/nursing mothers
  • 2.Scars, excessive terminal hair or tattoo on the studied area.
  • 3.Henna tattoo anywhere on the body (in case of studies involving hair dyes).
  • 4.Dermatological infection/pathology on the level of studied area.
  • 5.Hypersensitivity, allergy antecedent (to any cosmetic product, raw material or hair dye).
  • 6.Any clinically significant systemic or cutaneous disease, which may interfere with study treatment or procedures.
  • 7.Chronic illness which may influence the outcome of the study.
  • 8.Subjects on any medical treatment either systemic or topical which may interfere with the performance of the study treatment (presently or in the past 1 month).
  • 9.Subject in an exclusion period or participating in another food, cosmetic or therapeutic trial.

研究者

发起方
Saffron Naturele Pdt. Ltd.

相似试验

Photoallergic test of Advancexo | 临床试验